Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00943670
Brief Title: Corrected QT Interval Effects of Trastuzumab Emtansine (T-DM1) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer and the Safety and Tolerability of Combined T-DM1 and Pertuzumab in Patients With Early Disease Progression

First Submitted : July 19, 2009
First Submitted that Met QC Criteria : July 20, 2009
First Posted : July 22, 2009 (Estimate)

Results First Submitted : March 12, 2013
Results First Submitted that Met QC Criteria : March 12, 2013
Results First Posted : May 1, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : May 23, 2013
Last Update Posted : May 27, 2013 (Estimate)